Bergen, Norway, September 22, 2023: Lifecare AS (LIFE), a clinical stage medical
sensor company developing the next generation Continuous Glucose Monitor (CGM)
will participate at Redeye Medtech & Diagnostics Seminar. 

On 26 September at 1310 Lifecare will present latest developments from the
company at the Redeye Medtech & Diagnostics Seminar. The presentation deck is
enclosed. The presentation is live broadcasted and can be followed at
https://www.redeye.se/events/904816/redeye-theme-medtech-diagnostics-2 where the
replay and the presentations will be available afterwards.

Redeye Medtech & Diagnostics Seminar is scheduled from 09.00 to 15.10.

******

Lifecare AS is a clinical stage medical sensor company developing technology for
sensing and monitoring of various body analytes. Lifecare's main focus is to
bring the next generation of Continuous Glucose Monitoring ("CGM") systems to
market. Lifecare enables osmotic pressure as sensing principle, combined with
the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on
the sensor body for read-out of pressure variations. LifecareŽs sensor
technology is referred to as "Sencell" and is suitable for identifying and
monitoring the occurrence of a wide range of analytes and molecules in the human
body.

******

For further information, please contact: 

Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,
asle.wingsternes@lifecare.no, +47 41 61 42 52